Profil
Dr. Brandon Fradd is a Founder & Portfolio Manager at Wyvern Medical Fund LP.
Dr. Fradd was previously employed as a Founder by Apollo Medical Partners LP.
He received his undergraduate degree from Princeton University, a graduate degree from the University of Oxford and a doctorate degree from Harvard University.
Aktive Positionen von Brandon Fradd
| Unternehmen | Position | Beginn |
|---|---|---|
Wyvern Medical Fund LP
Wyvern Medical Fund LP Investment ManagersFinance Wyvern Medical Funds focuses on long/short investments in the life sciences sector, with specific emphasis on pharmaceuticals. In an effort to generate consistent returns, the firm relies on precise implementation of quantitative insights at particular moments in market development. Wyvern's approach seeks to gain an understanding of the likely outcomes of FDA clinical trials and to accurately predict these outcomes through rigorous quantitative analysis of a company's fundamentals and trading history. | Gründer | 01.01.2009 |
Ehemalige bekannte Positionen von Brandon Fradd
| Unternehmen | Position | Ende |
|---|---|---|
Apollo Medical Partners LP
Apollo Medical Partners LP Investment ManagersFinance Apollo Medical Partners is a long/short hedge fund manager that invests in the marketable and non-marketable securities of biotechnology, medical products and medical services companies | Corporate Officer/Principal | 02.10.1995 |
Ausbildung von Brandon Fradd
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Wyvern Medical Fund LP
Wyvern Medical Fund LP Investment ManagersFinance Wyvern Medical Funds focuses on long/short investments in the life sciences sector, with specific emphasis on pharmaceuticals. In an effort to generate consistent returns, the firm relies on precise implementation of quantitative insights at particular moments in market development. Wyvern's approach seeks to gain an understanding of the likely outcomes of FDA clinical trials and to accurately predict these outcomes through rigorous quantitative analysis of a company's fundamentals and trading history. | Finance |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apollo Medical Partners LP
Apollo Medical Partners LP Investment ManagersFinance Apollo Medical Partners is a long/short hedge fund manager that invests in the marketable and non-marketable securities of biotechnology, medical products and medical services companies | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















